# First-in-Human (FIH) Study of the Xeltis Hemodialysis Access Graft

> **NCT04898153** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Xeltis** · enrollment: 20 (actual)

## Conditions studied

- End Stage Renal Disease
- End Stage Renal Failure on Dialysis

## Interventions

- **DEVICE:** aXess

## Key facts

- **NCT ID:** NCT04898153
- **Lead sponsor:** Xeltis
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-06-10
- **Primary completion:** 2023-03-24
- **Final completion:** 2027-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04898153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04898153, "First-in-Human (FIH) Study of the Xeltis Hemodialysis Access Graft". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04898153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*